
Ro autoantigens are of clinical significance because antibodies directed against them are found in most patients with primary Sjogren syndrome, subacute cutaneous lupus erythematosus (SLE), neonatal lupus erythematosus, ANA-negative lupus erythematosus and systemic lupus erythematosus-like disease secondary to homozygous C2 or C4 complement deficiency. Ro/SSA is a ribonucleoprotein that binds to autoantibodies in 35 to 50% of patients with SLE and in up to 97% of patients with Sjogren syndrome. The Ro/SSA particle consists of a single immunoreactive protein noncovalently bound with one of four small RNA molecules. Most anti-Ro/SSA-positive sera antibodies detect not only the main protein, but also a smaller Ro/SSA protein. The genes which encode the smaller and larger proteins map to human chromosomes 11p15.5 and 1q31, respectively. La/SSB is an autoimmune RNA-binding protein that plays a role in the transcription of RNA polymerase III was originally defined by its reactivity with autoantibodies from patients with Sjogren syndrome and SLE.
Informations pour la commande
| Nom du produit | Ref. Catalogue | COND. | Prix HT | QTÉ | Favoris | |
Anticorps 52 kDa Ro/SSA (E-11) | sc-48430 | 200 µg/ml | RMB2422.00 | |||
52 kDa Ro/SSA (E-11): m-IgG Fc BP-HRP Kit | sc-536844 | 200 µg Ab; 10 µg BP | RMB2715.00 | |||
52 kDa Ro/SSA (E-11): m-IgGκ BP-HRP Kit | sc-534011 | 200 µg Ab; 40 µg BP | RMB2715.00 | |||
52 kDa Ro/SSA (E-11): m-IgG1 BP-HRP Kit | sc-544854 | 200 µg Ab; 20 µg BP | RMB2715.00 |